Ceribell, Inc.
CBLL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001861107
In the last 90 days, Ceribell, Inc. insiders filed 0 open-market purchases and 16 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $593.9M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:23 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $53.4M (60.0% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 |
| Revenue | $89.1M | $65.4M |
| Cost of revenue | $10.8M | $8.69M |
| Gross profit | $78.3M | $56.8M |
| Operating expenses | $136.7M | $96.5M |
| Research and development | $19.1M | $13.6M |
| Selling, general and administrative | $44.5M | $33.8M |
| Operating income | -$58.4M | -$39.7M |
| Income tax | $0 | – |
| Net income | -$53.4M | -$40.5M |
| EPS, basic | $-1.46 | $-3.39 |
| EPS, diluted | $-1.46 | $-3.39 |
| Weighted shares, basic | 36.5M | 11.9M |
| Weighted shares, diluted | 36.5M | 11.9M |
| Margins and growth | ||
| Gross margin | 87.9% | 86.7% |
| Operating margin | -65.6% | -60.7% |
| Net margin | -60.0% | -61.8% |
| Revenue growth, year over year | +36.1% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 |
| Cash and equivalents | $40.5M | $194.4M |
| Short-term investments | $118.8M | – |
| Accounts receivable | $15.1M | $10.9M |
| Inventory | $7.29M | $6.94M |
| Total current assets | $186.7M | $217.3M |
| Property, plant and equipment | $2.03M | $2.31M |
| Total assets | $195.8M | $225.4M |
| Accounts payable | $2.84M | $1.14M |
| Total current liabilities | $19.2M | $13.0M |
| Total liabilities | $40.5M | $34.2M |
| Shareholders' equity | $155.3M | $191.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 25, 2025 |
| Operating cash flow | -$40.8M | -$35.0M |
| Capital expenditures | $767.0K | $1.34M |
| Free cash flow | -$41.6M | -$36.4M |
| Depreciation and amortization | $1.34M | $1.14M |
| Stock-based compensation | $12.2M | $5.41M |
| Investing cash flow | -$118.1M | -$1.60M |
| Financing cash flow | $5.05M | $196.5M |
| Net change in cash | -$153.9M | $159.9M |
| Ratio | ||
| Stock-based compensation, % of revenue | 13.7% | 8.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.